HALEON PLC

HLN
Delayed London Stock Exchange - 11:35 2022-12-05 am EST
295.00 GBX +1.22%

Turn to zoom
Prev.295.00000000
Open292.75000000
High295.85000000
Low287.75000000
Volume11 415 002
Latest news
11/22
11/22
11/22
11/22
Chart HALEON PLC
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance301317308
Spread/Res.-2,0%-6,8%-4,2%
Spread/Supp.5,7%20%19%
Support279246247
Financials
Sales 2022 10 855 M 13 236 M 13 236 M
Net income 2022 1 468 M 1 790 M 1 790 M
Net Debt 2022 10 205 M 12 444 M 12 444 M
P/E ratio 2022 18,9x
Yield 2022 1,06%
Capitalization 27 187 M 33 150 M 33 150 M
EV / Sales 2022 3,44x
EV / Sales 2023 3,09x
Nbr of Employees 22 000
Free-Float 61,5%
Company
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows:
- oral health products (28.5%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.;
- Pain relief...
Sector :
Other Pharmaceuticals
Calendar :
2023-03-23 Earnings Release

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Last Close Price 295,00 GBX
Average target price 325,64 GBX
Spread / Average Target 10,4%